Overview

Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis

Status:
Recruiting
Trial end date:
2023-12-05
Target enrollment:
Participant gender:
Summary
This randomized clinical trial evaluates the clinical and microbiological (microbial complexes and changes in the diversity of the submucosal biofilm) effects of MTZ+AMX as adjuncts to anti-infectious surgical treatment plus Er: YAG in the treatment of peri-implantitis.
Phase:
N/A
Details
Lead Sponsor:
University of Guarulhos
Collaborator:
ITI Foundation
Treatments:
Amoxicillin
Metronidazole